{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T23:58:42Z","timestamp":1778975922057,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["bprch.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Haematology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.beha.2016.09.004","type":"journal-article","created":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T08:30:53Z","timestamp":1478248253000},"page":"5-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Molecular pathogenesis of splenic and nodal marginal zone lymphoma"],"prefix":"10.1016","volume":"30","author":[{"given":"Valeria","family":"Spina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2016.09.004_bib1","series-title":"World Health Organization classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"issue":"8","key":"10.1016\/j.beha.2016.09.004_bib2","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1182\/blood-2013-07-515155","article-title":"Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?","volume":"123","author":"Xochelli","year":"2014","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.beha.2016.09.004_bib3","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.3324\/haematol.2010.025437","article-title":"Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma","volume":"95","author":"Zibellini","year":"2010","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.beha.2016.09.004_bib4","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/leu.2012.3","article-title":"Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications","volume":"26","author":"Bikos","year":"2012","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.beha.2016.09.004_bib5","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1158\/1078-0432.CCR-15-1170","article-title":"An immunogenetic signature of ongoing antigen interactions in splenic marginal zone lymphoma expressing IGHV1-2*04 receptors","volume":"22","author":"Bikos","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.beha.2016.09.004_bib6","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1182\/blood.V99.4.1299","article-title":"Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course","volume":"99","author":"Algara","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.beha.2016.09.004_bib7","first-page":"470","article-title":"Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection","volume":"90","author":"Traverse-Glehen","year":"2005","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.beha.2016.09.004_bib8","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1038\/leu.2012.207","article-title":"Selection of antigen receptors in splenic marginal-zone lymphoma: further support from the analysis of the immunoglobulin light-chain gene repertoire","volume":"26","author":"Bikos","year":"2012","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.beha.2016.09.004_bib9","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1182\/blood-2011-03-341651","article-title":"Splenic marginal zone lymphoma with VH1-02 gene rearrangement expresses poly- and self-reactive antibodies with similar reactivity","volume":"118","author":"Warsame","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.beha.2016.09.004_bib10","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2014.107680","article-title":"A\u00a0restricted IGHV gene repertoire in splenic marginal zone lymphoma is associated with autoimmune disorders","volume":"99","author":"Brisou","year":"2014","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.beha.2016.09.004_bib11","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3324\/haematol.2012.083386","article-title":"Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review","volume":"98","author":"Van den Brand","year":"2013","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.beha.2016.09.004_bib12","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1182\/asheducation-2014.1.590","article-title":"Hepatitis C virus-associated B-cell non-Hodgkin lymphomas","volume":"2014","author":"Vannata","year":"2014","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"4","key":"10.1016\/j.beha.2016.09.004_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1525-1578(10)60525-9","article-title":"Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma","volume":"6","author":"Tr\u00f8en","year":"2004","journal-title":"J\u00a0Mol Diagn"},{"issue":"5","key":"10.1016\/j.beha.2016.09.004_bib14","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1182\/blood-2004-10-3898","article-title":"Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis","volume":"106","author":"Ruiz-Ballesteros","year":"2005","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.beha.2016.09.004_bib15","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1182\/blood-2014-08-596247","article-title":"DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features","volume":"125","author":"Arribas","year":"2015","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.beha.2016.09.004_bib16","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1038\/sj.leu.2404853","article-title":"MicroRNA losses in the frequently deleted region of 7q in SMZL","volume":"21","author":"Ruiz-Ballesteros","year":"2007","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.beha.2016.09.004_bib17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2141.2011.08848.x","article-title":"MicroRNA expression profile in splenic marginal zone lymphoma","volume":"156","author":"Bouteloup","year":"2012","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.beha.2016.09.004_bib18","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/modpathol.2012.220","article-title":"Splenic marginal zone lymphoma: comprehensive analysis of gene expression and miRNA profiling","volume":"26","author":"Arribas","year":"2013","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.beha.2016.09.004_bib19","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1182\/blood-2011-02-339556","article-title":"Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets","volume":"119","author":"Arribas","year":"2012","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.beha.2016.09.004_bib20","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2010-02-267476","article-title":"Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group","volume":"116","author":"Salido","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.beha.2016.09.004_bib21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/path.2665","article-title":"Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis","volume":"220","author":"Watkins","year":"2010","journal-title":"J\u00a0Pathol"},{"issue":"9","key":"10.1016\/j.beha.2016.09.004_bib22","doi-asserted-by":"crossref","first-page":"e24939","DOI":"10.1371\/journal.pone.0024939","article-title":"Molecular characterization of the region 7q22.1 in splenic marginal zone lymphomas","volume":"6","author":"Robledo","year":"2011","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.beha.2016.09.004_bib23","doi-asserted-by":"crossref","first-page":"e44997","DOI":"10.1371\/journal.pone.0044997","article-title":"An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphoma","volume":"7","author":"Watkins","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.beha.2016.09.004_bib24","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1365-2141.2012.09226.x","article-title":"High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma","volume":"158","author":"Fresquet","year":"2012","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.beha.2016.09.004_bib25","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2010-01-264275","article-title":"Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome","volume":"117","author":"Rinaldi","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.beha.2016.09.004_bib26","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1182\/blood-2016-02-696757","article-title":"The genetics of nodal marginal zone lymphoma","volume":"128","author":"Spina","year":"2016","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.beha.2016.09.004_bib27","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1084\/jem.20120910","article-title":"Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma","volume":"209","author":"Kiel","year":"2012","journal-title":"J\u00a0Exp Med"},{"issue":"9","key":"10.1016\/j.beha.2016.09.004_bib28","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20120904","article-title":"The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development","volume":"209","author":"Rossi","year":"2012","journal-title":"J\u00a0Exp Med"},{"issue":"18","key":"10.1016\/j.beha.2016.09.004_bib29","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1158\/1078-0432.CCR-14-2759","article-title":"Genetics and prognostication in splenic marginal zone lymphoma: revelations from deep sequencing","volume":"21","author":"Parry","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.beha.2016.09.004_bib30","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/leu.2013.365","article-title":"Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation","volume":"28","author":"Mart\u00ednez","year":"2014","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.beha.2016.09.004_bib31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4049\/jimmunol.179.1.195","article-title":"Synergism between NF-kappa B1\/p50 and Notch2 during the development of marginal zone B lymphocytes","volume":"179","author":"Moran","year":"2007","journal-title":"J\u00a0Immunol"},{"issue":"5","key":"10.1016\/j.beha.2016.09.004_bib32","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1084\/jem.20132203","article-title":"Identification of a human splenic marginal zone B cell precursor with NOTCH2-dependent differentiation properties","volume":"211","author":"Descatoire","year":"2014","journal-title":"J\u00a0Exp Med"},{"issue":"5","key":"10.1016\/j.beha.2016.09.004_bib33","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/bjh.13052","article-title":"Molecular lesions of signalling pathway genes in clonal B-cell lymphocytosis with marginal zone features","volume":"167","author":"Bruscaggin","year":"2014","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.beha.2016.09.004_bib34","doi-asserted-by":"crossref","first-page":"e83244","DOI":"10.1371\/journal.pone.0083244","article-title":"Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma","volume":"8","author":"Parry","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.beha.2016.09.004_bib35","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/leu.2013.319","article-title":"Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia","volume":"28","author":"Arruga","year":"2014","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.beha.2016.09.004_bib36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.coi.2008.03.014","article-title":"Peripheral B cell subsets","volume":"20","author":"Allman","year":"2008","journal-title":"Curr Opin Immunol"},{"issue":"18","key":"10.1016\/j.beha.2016.09.004_bib37","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1182\/blood-2011-06-359166","article-title":"Alteration of BIRC3 and multiple other NF-\u03baB pathway genes in splenic marginal zone lymphoma","volume":"118","author":"Rossi","year":"2011","journal-title":"Blood"},{"issue":"39","key":"10.1016\/j.beha.2016.09.004_bib38","doi-asserted-by":"crossref","first-page":"26960","DOI":"10.1074\/jbc.M114.598763","article-title":"I\u03baB kinase \u03b2 (IKBKB) mutations in lymphomas that constitutively activate canonical nuclear factor \u03baB (NF\u03baB) signaling","volume":"289","author":"Kai","year":"2014","journal-title":"J\u00a0Biol Chem"},{"issue":"20","key":"10.1016\/j.beha.2016.09.004_bib39","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1182\/blood-2008-08-174110","article-title":"The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas","volume":"113","author":"Novak","year":"2009","journal-title":"Blood"},{"issue":"7247","key":"10.1016\/j.beha.2016.09.004_bib40","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nature07968","article-title":"Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma","volume":"459","author":"Compagno","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.beha.2016.09.004_bib41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nm.3435","article-title":"Pharmacological and genomic profiling identifies NF-\u03baB-targeted treatment strategies for mantle cell lymphoma","volume":"20","author":"Rahal","year":"2014","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.beha.2016.09.004_bib42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/asheducation-2014.1.113","article-title":"Role of MYD88 in lymphoplasmacytic lymphoma diagnosis and pathogenesis","volume":"2014","author":"Rossi","year":"2014","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"3","key":"10.1016\/j.beha.2016.09.004_bib43","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1084\/jem.20131424","article-title":"Consequences of the recurrent MYD88 (L265P) somatic mutation for B cell tolerance","volume":"211","author":"Wang","year":"2014","journal-title":"J\u00a0Exp Med"},{"issue":"4","key":"10.1016\/j.beha.2016.09.004_bib44","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3324\/haematol.2011.054080","article-title":"BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas","volume":"97","author":"Yan","year":"2012","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.beha.2016.09.004_bib45","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/leu.2012.257","article-title":"IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstr\u00f6m macroglobulinemia\/lymphoplasmacytic lymphomas","volume":"27","author":"Gachard","year":"2013","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.beha.2016.09.004_bib46","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1182\/blood-2012-09-454355","article-title":"MYD88 L265P in Waldenstr\u00f6m macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction","volume":"121","author":"Xu","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.09.004_bib47","first-page":"252318","article-title":"CD79B and MYD88 mutations in splenic marginal zone lymphoma","volume":"2013","author":"Tr\u00f8en","year":"2013","journal-title":"ISRN Oncol"},{"issue":"13","key":"10.1016\/j.beha.2016.09.004_bib48","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1182\/blood-2012-09-457101","article-title":"Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms","volume":"121","author":"Varettoni","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.beha.2016.09.004_bib49","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/modpathol.2014.120","article-title":"MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma","volume":"28","author":"Hamadeh","year":"2015","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.beha.2016.09.004_bib50","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/PAS.0000000000000411","article-title":"MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma","volume":"39","author":"Martinez-Lopez","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.beha.2016.09.004_bib51","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1186\/s12885-015-1766-z","article-title":"Whole exome sequencing of microdissected splenic marginal zone lymphoma: a study to discover novel tumor-specific mutations","volume":"15","author":"Peveling-Oberhag","year":"2015","journal-title":"BMC Cancer"},{"issue":"7332","key":"10.1016\/j.beha.2016.09.004_bib52","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","article-title":"Oncogenically active MYD88 mutations in human lymphoma","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"issue":"5870","key":"10.1016\/j.beha.2016.09.004_bib53","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1126\/science.1153629","article-title":"Oncogenic CARD11 mutations in human diffuse large B cell lymphoma","volume":"319","author":"Lenz","year":"2008","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.beha.2016.09.004_bib54","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1073\/pnas.1012858108","article-title":"B\u00a0cell homeostasis and plasma cell homing controlled by Kr\u00fcppel-like factor 2","volume":"108","author":"Winkelmann","year":"2011","journal-title":"Proc Natl Acad Sci U. S. A"},{"issue":"5","key":"10.1016\/j.beha.2016.09.004_bib55","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/leu.2014.330","article-title":"KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype","volume":"29","author":"Clipson","year":"2015","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.beha.2016.09.004_bib56","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/leu.2014.294","article-title":"The Kr\u00fcppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma","volume":"29","author":"Piva","year":"2015","journal-title":"Leukemia"},{"issue":"16","key":"10.1016\/j.beha.2016.09.004_bib57","doi-asserted-by":"crossref","first-page":"6976","DOI":"10.18632\/oncotarget.2106","article-title":"Deletion of Ptprd and Cdkn2a cooperate to accelerate tumorigenesis","volume":"5","author":"Ortiz","year":"2014","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.beha.2016.09.004_bib58","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.immuni.2007.07.012","article-title":"Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs","volume":"27","author":"Xie","year":"2007","journal-title":"Immunity"},{"issue":"31","key":"10.1016\/j.beha.2016.09.004_bib59","doi-asserted-by":"crossref","first-page":"10883","DOI":"10.1073\/pnas.0805186105","article-title":"NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF: BAFF-R-mediated survival signals in B cells","volume":"105","author":"Sasaki","year":"2008","journal-title":"Proc Natl Acad Sci U. S. A"},{"issue":"10","key":"10.1016\/j.beha.2016.09.004_bib60","doi-asserted-by":"crossref","first-page":"e1000518","DOI":"10.1371\/journal.pbio.1000518","article-title":"Non-canonical NF-\u03baB activation and abnormal B cell accumulation in mice expressing ubiquitin protein ligase-inactive c-IAP2","volume":"8","author":"Conze","year":"2010","journal-title":"PLoS Biol"},{"issue":"2","key":"10.1016\/j.beha.2016.09.004_bib61","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1073\/pnas.1013168108","article-title":"Kr\u00fcppel-like factor 2 (KLF2) regulates B-cell reactivity, subset differentiation, and trafficking molecule expression","volume":"108","author":"Hart","year":"2011","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Best Practice & Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692616300779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692616300779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T03:52:54Z","timestamp":1601178774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692616300779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":61,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1521692616300779"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2016.09.004","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular pathogenesis of splenic and nodal marginal zone lymphoma","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2016.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}